Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
Peghin M, De Martino M, Fabris M, Palese A, Visintini E, Graziano E, Gerussi V, Bontempo G, D'Aurizio F, Biasotto A, Sartor A, Pipan C, Marzinotto S, Curcio F, Bouza E, Isola M, Tascini C. Peghin M, et al. Among authors: tascini c. J Clin Microbiol. 2021 Oct 19;59(11):e0113821. doi: 10.1128/JCM.01138-21. Epub 2021 Aug 11. J Clin Microbiol. 2021. PMID: 34379530 Free PMC article.
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients.
Bassetti M, Villa G, Ansaldi F, De Florentiis D, Tascini C, Cojutti P, Righi E, Sartor A, Crapis M, De Rosa FG, Pea F, Menichetti F. Bassetti M, et al. Among authors: tascini c. Intensive Care Med. 2015 Feb;41(2):366-8. doi: 10.1007/s00134-014-3571-6. Epub 2014 Dec 2. Intensive Care Med. 2015. PMID: 25447803 Free article. No abstract available.
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.
Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Toniutto P, Wauters J, Laleman W, Tascini C, Menichetti F, Luzzati R, Brugnaro P, Mesini A, Raviolo S, De Rosa FG, Lagunes L, Rello J, Dimopoulos G, Colombo AL, Nucci M, Vena A, Bouza E, Muñoz P, Tumbarello M, Losito R, Martin-Loeches I, Viscoli C. Bassetti M, et al. Among authors: tascini c. Intensive Care Med. 2017 Apr;43(4):509-518. doi: 10.1007/s00134-017-4717-0. Epub 2017 Mar 7. Intensive Care Med. 2017. PMID: 28271321 Free article.
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.
Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C. Bassetti M, et al. Among authors: tascini c. Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May. Transplant Direct. 2017. PMID: 28573191 Free PMC article.
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito AR, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE Study Group. Bassetti M, et al. Among authors: tascini c. Int J Antimicrob Agents. 2019 Apr;53(4):408-415. doi: 10.1016/j.ijantimicag.2018.11.001. Epub 2018 Nov 8. Int J Antimicrob Agents. 2019. PMID: 30415002 Free article.
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study.
Bassetti M, Carannante N, Pallotto C, Righi E, Di Caprio G, Bernardo M, Sodano G, Mallardo E, Francisci D, Sartor A, Graziano E, Tascini C. Bassetti M, et al. Among authors: tascini c. J Glob Antimicrob Resist. 2019 Jun;17:109-111. doi: 10.1016/j.jgar.2018.11.014. Epub 2018 Nov 20. J Glob Antimicrob Resist. 2019. PMID: 30468915
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study).
Bassetti M, Vena A, Giacobbe DR, Falcone M, Tiseo G, Giannella M, Pascale R, Meschiari M, Digaetano M, Oliva A, Rovelli C, Carannante N, Losito AR, Carbonara S, Mariani MF, Mastroianni A, Angarano G, Tumbarello M, Tascini C, Grossi P, Mastroianni CM, Mussini C, Viale P, Menichetti F, Viscoli C, Russo A; CEFTABUSE Study Group. Bassetti M, et al. Among authors: tascini c. Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa139. doi: 10.1093/ofid/ofaa139. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32462046 Free PMC article.
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
Quartuccio L, Sonaglia A, McGonagle D, Fabris M, Peghin M, Pecori D, De Monte A, Bove T, Curcio F, Bassi F, De Vita S, Tascini C. Quartuccio L, et al. Among authors: tascini c. J Clin Virol. 2020 Aug;129:104444. doi: 10.1016/j.jcv.2020.104444. Epub 2020 May 15. J Clin Virol. 2020. PMID: 32570043 Free PMC article.
348 results